Performance Evaluation of Vapour Compression Refrigeration System in Heating and Cooling mode assisted with IoT Technology
Journals Fringe Multi-Engineering Proceedings · 2025
DOI: 10.69996/fmep.2025013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journals Fringe Multi-Engineering Proceedings, 2025. Verfasst von Shubham Mehra und 6 weiteren Autor:innen.
Abstract (Originalsprache)
The Heating and Cooling strategy for the vapour compression refrigeration cycle has been characterized by temperature and pressure limits. The theoretical model was established to analyze the performance indicators, viz. Coefficient of Performance (COP), exergy loss, exergy analysis, Second Law efficiencies, also catering to different sets of refrigerants present in the market these days. Also, with advancement in the field of science and research, the search for the better is the growth, so talking about all the different refrigerants and comparing based on performance indicators, too. The Internet of Things has been incorporated to make the controls easier and user-friendly.
Zitieren
APA
Mehra, S., Gandotra, D., Yadav, N., Umar, M. T., Nandan, K., J, K., & Jain, V. (2025). Performance Evaluation of Vapour Compression Refrigeration System in Heating and Cooling mode assisted with IoT Technology. Journals Fringe Multi-Engineering Proceedings. https://doi.org/10.69996/fmep.2025013
Vancouver
Mehra S, Gandotra D, Yadav N, Umar MT, Nandan K, J K, et al. Performance Evaluation of Vapour Compression Refrigeration System in Heating and Cooling mode assisted with IoT Technology. Journals Fringe Multi-Engineering Proceedings. 2025. doi:10.69996/fmep.2025013
BibTeX
@article{Mehra2025,
author = {Mehra, Shubham and Gandotra, Daksh and Yadav, Nitin and Umar, Md Taufique and Nandan, Keshav and J, Keshav and Jain, Vaibhav},
title = {Performance Evaluation of Vapour Compression Refrigeration System in Heating and Cooling mode assisted with IoT Technology},
journal = {Journals Fringe Multi-Engineering Proceedings},
year = {2025},
doi = {10.69996/fmep.2025013}
}
EUVIMED